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 Recent estimates of waste in health care spending in the United States have 
reached a threshold of one trillion dollars (Shrank et al. 2019), equivalent to the gross 
domestic product of the 17th largest economy in the world. The major contributors to 
wasteful spending span failures of care delivery, over-treatment and low-quality care, 
fraud, administrative complexity and redundancies, inadequate care coordination, and 
widely variable resource pricing (Shrank et al. 2019). 
 
Determining the factors that drive wasteful spending is a complex problem since waste 
can arise anywhere from daily individual decisions made by clinicians and their allies to 
decisions made by health authorities and legislators at the regional or national systems-
level. Considering only individual clinical encounters between clinicians and patients, 
high quality care demands seamless integration of rapidly advancing clinical knowledge, 
compassionate care, and electronic data all within a fifteen-minute visit. Efficiently 
securing a diagnosis, work-up, and treatment plan consistent with today’s gold standard 
of care in this continuously evolving and demanding environment increases the 
probability of error. An error in this pathway such as a missed diagnosis, an 
inappropriate imaging study, or an ineffective treatment adds to the waste tally. 
Ultimately, the complexity of modern medicine leads to error resulting in waste, which 
leads to poor health care value.  
 
The complexity of modern health care delivery and the dire consequences of persistent 
wasteful care have led to the rising popularity of value-based care models, which are 
centered on the principle that optimal health care value is achieved when patient 
outcomes are maximized per unit cost to deliver those outcomes (Porter and Teisberg 
2006). If we can improve clinical outcomes without increasing costs, or preferably at lower 
cost, then we progress towards the goal of higher value care. Several value-inspired 
delivery models have emerged including regional patient-centered care homes, system-
wide accountable care organizations, and bundled payments for diseases or intervention 
packages. Despite their promise, these solutions have yet to address the complexity of 
individual decision making in a large lake of data. The probability of misdiagnosis and 
error rises with increased complexity and uncertainty, which ultimately reinforces 
barriers to high value care. Error is a key unifying thread among the major contributors 
to wasteful spending. Reduced error rates in clinical decision making would lead to a 
reduction in inappropriate care delivery, fewer delays in receiving appropriate care, and 
improved care coordination. 
 
Despite world-class medical education and significant resources devoted to cutting-edge 
care, over 80,000 patients die in the United States annually due to diagnostic error 
(Newman-Toker and Pronovost 2009). These errors may arise, in part, from a failure to 
integrate the best-available data for every individual clinical decision. Our knowledge of 
human physiology and pathology rapidly advances year over year, as do our methods for 
collecting and analyzing clinical data. We have attempted to disseminate new knowledge 
and tools by introducing evidence-based guidelines, checklists, and simplified rules-based 
algorithms. Clinicians are called upon to make predictions from all of these inputs at the 
point of care, but these predictions are subject to error because of our limited capacity to 
integrate all the data. Our analytic and cognitive plateau needs a new approach that is 
capable of generating accurate predictions and actionable insights from overwhelming 
amounts of complex data. New approaches that improve prediction accuracy in the face of 
complex and dynamic datasets should decrease error and, ultimately, health care waste.  
 
Machine learning has tremendous potential to help reduce error, curtail waste and 
ultimately improve value through generating accurate clinical predictions. Recent 
successes have provided international validation of machine learning algorithms applied 
to diagnostic tasks in medical imaging with classification accuracy performance that 
rivals or exceeds human performance (McKinney et al. 2020). Successful diagnostic 
algorithms have also shown promise in the fields of dermatology and pathology.  
Automatic patient safety event flagging from clinical documentation through the flagging 
of important index events (e.g., falls, missed medications, or trends in persistent 
caregiver concerns) could prevent costly sequalae of compromised patient safety in both 
inpatient and outpatient settings. Local, real-time social media and institutional data 
could be combined to forecast institutional resource needs to combat seasonal spikes in 
infectious disease outbreaks or other public health events. Machine learning can also be 
used to predict optimal patient treatment regimens based on relevant demographics, 
clinical presentation factors and genomic data. Tailored treatment algorithms would 
reduce unnecessary or inappropriate care, and maximize the probability for favorable 
patient outcomes. Additional opportunities are provided in Table 1, aligned with major 
categories of waste. 
 
Waste Domain 
($, billions) 
Example Algorithm Opportunities 
i. Administrative 
Complexity 
(265.5) 
 Redundant or inappropriate 
billing/coding practices 
 
 Excess or redundant 
administrative personnel  
 Automatic coding based on 
clinical narratives and reports 
with natural language processing 
(e.g., patient complexity coding) 
 
 Health resource forecasting and 
optimization based on historical 
trends integrated with live social 
media sentiments (e.g., real-time 
prediction of seasonal infectious 
disease outbreaks) 
ii. Pricing Failures 
(230.7-240.5) 
 Costly medication research & 
development 
 
 Regional variability in resource 
pricing 
 Pattern recognition for 
accelerated drug discovery 
 
 Automated supplier price 
anomaly/outlier detection 
iii. Care Delivery 
Failures 
(102-165.7) 
 Preventable hospital-associated 
adverse events 
 
 Failure to capture preventative 
care opportunities 
 Automatic patient safety event 
flagging from clinical 
documentation (e.g., flagging of 
inpatient falls, missed 
medications, or nursing concerns) 
 
 Automatic chronic disease risk 
factor identification (e.g., 
individualized time-series 
analysis of biomarkers and 
compliance with therapies and/or 
guidelines) 
iv. Overtreatment, 
inappropriate care 
(75.7-101.2) 
 Misdiagnosis 
 
 Improper testing or therapeutic 
indications 
 Automated radiographic and 
pathological sample diagnosis 
(e.g., error reduction in missed or 
incorrect specimen diagnosis) 
 
 Individualized treatment 
recommendation engine using 
best available data (e.g., 
automatic recommendation of 
optimal testing strategies)  
v. Fraud 
(58.5-83.9) 
 Misrepresentation of illness or 
disability 
 Billing and utilization pattern 
anomaly detection (e.g., risk 
factor identification of anomalous 
use of health care resources) 
vi. Care Coordination 
Failure 
(27.2-78.2) 
 Preventable admissions for 
post-care or post-procedure 
complications 
 
 Failure of coordination of home 
medical equipment and 
resource needs 
 Readmission risk prediction (e.g., 
predictive analysis based on the 
confluence of clinical narrative, 
biomarkers, and imaging data)  
 
 Automated home medical 
equipment identification and 
sourcing (e.g., prediction for 
utilization of home mobility 
assistance needs) 
 
 
Table 1. Opportunities for machine learning applications to address challenges in 
wasteful health care spending. Contribution to wasteful spending estimates adapted from 
Shrank et al., 2019.  
 
Despite the promise of machine learning in medicine, there are significant limitations 
that have prevented widespread adoption. One of the major roadblocks in the current 
application of machine learning algorithms is the availability of sufficient high-quality 
data. Collecting, curating and labeling data is time consuming and expensive. Another 
key limitation is the interpretability of machine learning algorithm output. Clinicians 
may be wary to trust and implement a predictive model without knowing the underlying 
mechanism for how the algorithm arrived at its prediction. More recently, key ethical 
issues including health information privacy, industry relationships, bias and 
accountability for machine error have also been raised as important checkpoints that 
must be addressed (Char et al. 2018). Fortunately, these limitations are active areas of 
research. 
 The complexity of modern medicine, error and subsequent wasteful care is one of the key 
drivers of runaway health care spending in today's health care ecosystem. Value-based 
health care provides a framework for developing innovations with an aim to achieve 
higher quality at lower cost. Machine learning is poised to help reduce uncertainty in 
clinical decision making to serve the value-based health care mandate. Predictive models 
may also reveal modifiable health system factors to address care delivery shortcomings. 
While there are many challenges to operationalizing machine learning algorithms 
globally, the question remains whether we can afford not to. 
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